Introduction Over the past years, the incidence of thyroid cancer has surged not only in
Germany but also in other countries of the Western hemisphere. This surge was first and …

Background. Over the past ten years, the incidence rate of papillary thyroid carcinoma (PTC)
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …

Aims In this study, we examined BRAF mutation in a wide range of histiocytic and dendritic
cell neoplasms and compared its detection rate in each disease group. Methods and results …

Objective The purposes of this study were to identify risk factors for cervical lymph node
metastasis and to examine the association between BRAF V600E status and clinical …

BACKGROUND Papillary thyroid cancer (PTC) persistence or recurrence and the need for
long‐term surveillance can cause significant inconvenience and morbidity in patients …

Simple Summary Papillary thyroid carcinoma (PTC) represents 80–90% of all differentiated
thyroid carcinomas. PTC has a high rate of gene fusions and mutations, which can influence …

Background: Given the increasing incidence of papillary thyroid carcinoma despite stable
disease-specific mortality rates, the potential for the disease to reoccur is a key outcome to …

Papillary thyroid carcinoma (PTC), the most common malignancy of the endocrine system, is
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …

Objective The objective of this systematic review with meta‐analysis was to critically
evaluate the available data on the association of the BRAF V600E mutation and recurrence …

Background Few highly accurate tests can diagnose central lymph node metastasis (CLNM)
of papillary thyroid cancer (PTC). Genetic sequencing of tumor tissue has allowed the …